When Daybue is pulled from the market due to safety will Nueren have to pay back the milestone payments?
- Forums
- ASX - By Stock
- NEU
- Ann: Comment on research report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.85

Ann: Comment on research report, page-174
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.85 |
Change
0.000(0.00%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16 | $14.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.07 | 62 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16 | 14.070 |
6 | 302 | 13.630 |
7 | 749 | 13.490 |
1 | 2 | 13.240 |
1 | 1 | 13.050 |
Price($) | Vol. | No. |
---|---|---|
12.070 | 1 | 1 |
12.220 | 630 | 3 |
12.480 | 38 | 1 |
12.710 | 705 | 1 |
12.850 | 944 | 3 |
Last trade - 09.52am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online